TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,428,138 | +99.8% | 1,135,092 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $6,719,745 | +48.2% | 1,135,092 | +6.4% | 0.00% | +100.0% |
| Q2 2022 | $4,533,046 | -53.1% | 1,066,599 | +5.0% | 0.00% | -50.0% |
| Q1 2022 | $9,656,663 | -50.3% | 1,015,422 | -0.7% | 0.00% | -50.0% |
| Q4 2021 | $19,436,000 | -29.2% | 1,022,922 | +24.0% | 0.00% | -33.3% |
| Q3 2021 | $27,450,000 | -36.7% | 824,824 | -26.3% | 0.01% | -33.3% |
| Q2 2021 | $43,398,000 | -16.0% | 1,118,783 | +4.4% | 0.01% | -25.0% |
| Q1 2021 | $51,663,000 | -22.1% | 1,071,846 | -16.0% | 0.01% | -20.0% |
| Q4 2020 | $66,351,000 | +96.7% | 1,275,493 | +1.2% | 0.02% | +66.7% |
| Q3 2020 | $33,729,000 | +8548.5% | 1,260,410 | +6202.0% | 0.01% | – |
| Q2 2020 | $390,000 | -51.5% | 20,000 | -80.0% | 0.00% | – |
| Q1 2019 | $804,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |